First Commonwealth Financial Corp’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.42M | Buy |
7,641
+82
| +1% | +$15.2K | 0.31% | 57 |
|
2025
Q1 | $1.58M | Buy |
7,559
+352
| +5% | +$73.8K | 0.37% | 53 |
|
2024
Q4 | $1.28M | Buy |
7,207
+167
| +2% | +$29.7K | 0.3% | 59 |
|
2024
Q3 | $1.39M | Sell |
7,040
-32
| -0.5% | -$6.32K | 0.33% | 51 |
|
2024
Q2 | $1.21M | Buy |
7,072
+733
| +12% | +$126K | 0.31% | 56 |
|
2024
Q1 | $1.15M | Sell |
6,339
-597
| -9% | -$109K | 0.31% | 58 |
|
2023
Q4 | $1.07M | Sell |
6,936
-216
| -3% | -$33.5K | 0.33% | 47 |
|
2023
Q3 | $1.07M | Buy |
7,152
+346
| +5% | +$51.6K | 0.36% | 48 |
|
2023
Q2 | $917K | Buy |
6,806
+217
| +3% | +$29.2K | 0.3% | 60 |
|
2023
Q1 | $1.05M | Sell |
6,589
-141
| -2% | -$22.5K | 0.38% | 54 |
|
2022
Q4 | $1.09M | Buy |
6,730
+4,069
| +153% | +$658K | 0.4% | 48 |
|
2022
Q3 | $357K | Hold |
2,661
| – | – | 0.15% | 130 |
|
2022
Q2 | $408K | Sell |
2,661
-499
| -16% | -$76.5K | 0.15% | 129 |
|
2022
Q1 | $512K | Hold |
3,160
| – | – | 0.16% | 115 |
|
2021
Q4 | $428K | Sell |
3,160
-1
| -0% | -$135 | 0.14% | 126 |
|
2021
Q3 | $341K | Sell |
3,161
-1
| -0% | -$108 | 0.12% | 136 |
|
2021
Q2 | $357K | Buy |
3,162
+350
| +12% | +$39.5K | 0.13% | 134 |
|
2021
Q1 | $305K | Buy |
2,812
+19
| +0.7% | +$2.06K | 0.12% | 138 |
|
2020
Q4 | $299K | Buy |
2,793
+25
| +0.9% | +$2.68K | 0.13% | 136 |
|
2020
Q3 | $243K | Buy |
2,768
+499
| +22% | +$43.8K | 0.11% | 146 |
|
2020
Q2 | $223K | Buy |
+2,269
| New | +$223K | 0.11% | 151 |
|
2019
Q1 | – | Sell |
-4,727
| Closed | -$436K | – | 142 |
|
2018
Q4 | $436K | Hold |
4,727
| – | – | 0.31% | 86 |
|
2018
Q3 | $447K | Buy |
4,727
+58
| +1% | +$5.49K | 0.3% | 85 |
|
2018
Q2 | $433K | Sell |
4,669
-208
| -4% | -$19.3K | 0.45% | 71 |
|
2018
Q1 | $462K | Buy |
+4,877
| New | +$462K | 0.49% | 63 |
|